[HTML][HTML] Biological Basis of Breast Cancer-Related Disparities in Precision Oncology Era

AN Neagu, P Bruno, KR Johnson, G Ballestas… - International Journal of …, 2024 - mdpi.com
Precision oncology is based on deep knowledge of the molecular profile of tumors, allowing
for more accurate and personalized therapy for specific groups of patients who are different …

[HTML][HTML] Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania

CI Filip, A Cătană, E Kutasi, SA Roman, MS Militaru… - Medicina, 2024 - mdpi.com
Breast cancer remains a significant contributor to morbidity and mortality within oncology.
Risk factors, encompassing genetic and environmental influences, significantly contribute to …

[HTML][HTML] Targeting Neoantigens in Cancer: Possibilities and Opportunities in Breast Cancer

Z Chaudhry, A Boyadzhyan, K Sasaninia, V Rai - Antibodies, 2024 - mdpi.com
As one of the most prevalent forms of cancer worldwide, breast cancer has garnered
significant attention within the clinical research setting. While traditional treatment employs a …

Challenges in the management of operable triple-negative breast cancer in a survivor of the B-cell acute lymphoblastic leukaemia: a case report

T Pavlin, A Blatnik, B Seruga - Frontiers in Oncology, 2024 - frontiersin.org
Background: Operable triple-negative breast cancer (TNBC) is an unfavourable subtype of
breast cancer which usually requires an aggressive perioperative systemic treatment. When …

[HTML][HTML] Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing

IO Ban, A Chabert, T Guignard, J Puechberty… - Frontiers in …, 2024 - frontiersin.org
Introduction Accurate identification and characterization of Large Genomic Rearrangements
(LGR), especially duplications, are crucial for precise diagnosis and risk assessment. In this …